Press "Enter" to skip to content

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to enhance the utility of the Orange Book to foster drug competition

FDA announces new policies to ensure the Orange Book provides the greatest benefit to patients and providers, and generic drug developers.

Also Read:   UPDATE: Potential risks with liquid-filled intragastric balloons - Letter to Health Care Providers